KBP-336 is a dual amylin and calcitonin receptor agonist (DACRA). This compound exhibits antidiabetic and insulin-sensitizing properties, improving blood glucose levels, spatial learning, and memory capabilities in diabetic rats while simultaneously reducing their blood sugar levels. Additionally, KBP-336 alleviates pain-like symptoms in rats with osteoarthritis and contributes to weight and fat reduction. It is useful for research on conditions such as diabetes, obesity, and arthritis.